This can lead to weight cycling, which has been shown to cause fluctuations in cardiovascular risk factors, such as blood pressure, heart rate, sympathetic activity, and circulating levels of glucose, lipids and insulin
Long-term use: whether the changes last, and what safety looks like beyond the trial windows, is unknown
Zhou, X., Menche, J., Barabsi, A
38 Oral Route of Semaglutide The degradation of peptide-based drugs by proteolytic enzymes, the low permeability of intestinal epithelium and its mucus layer and the low pH of the gastrointestinal tract, are the major barriers preventing the oral administration of GLP-1RAs
After another 30 days, if your blood sugar isnt well-managed, your doctor may increase your daily dose to 14 mg